9 / 20
Page 31
Notes:
conferenceseries
.com
Volume 4
Neonatal and Pediatric Medicine
Pediatrics Neonatal Care 2018
November 12-13, 2018
November 12-13, 2018 Dubai, UAE
22
nd
World Congress on
Pediatrics, Neonatology & Primary Care
Recent advances in understanding the pathophysiology and management of cystic fibrosis
Abeer Mohi El-Din Saleh
International Medical Center Hospital, Egypt
A
lthough cystic fibrosis is a monogenic, predominantly Caucasian, autosomal recessive disease, increasing numbers of
patients with cystic fibrosis are being identified in other large populations. It was first recognized as a specific disease by
Dorothy Andersen in 1938, with descriptions that fit the condition occurring at least as far back as 1595. The cystic fibrosis
trans membrane conductance regulator gene was identified in 1989. It affects multiple organs, including the intestine, sweat
glands, pancreas and the reproductive system, but cystic fibrosis lung disease causes most morbidity and leads to premature
mortality. It’s now predicted that children born with cystic fibrosis in the 2000s will survive into their 50s. The focus of this review
is to summarize some of the recent advances that have taken place in our understanding of the recent advances in diagnosing and
managing cystic fibrosis.
Biography
Abeer Mohi El-Din Saleh has completed Bachelor’s degree from Ain Shams University Faculty of Medicine in 1995, Master’s degree from the same university in
2001 and MRCPCH London, UK in 2013. She has previously worked in Yeovil District Hospital, UK. She is currently is working as a Pediatric Consultant in the
International Medical Center Hospital and Nasser Institute, Cairo, Egypt.
Abeer Mohi El-Din Saleh, Neonat Pediatr Med 2018, Volume 4
DOI: 10.4172/2572-4983-C3-008